Various interventions are being tested in clinical trials for their safety and efficacy. Here are a few diseases that have the potential to be addressed by Epirubicin Hydrochloride treatment: Breast Cancer, Sarcoma, Esophageal Cancer and Protocol Specific Unspecified Adult Solid Tumor. There are currently 2 clinical trials ongoing in the State of Tennessee for Epirubicin Hydrochloride. Of these 1 clinical trials are currently active in Knoxville, Tennessee.
Some clinical studies that are currently on-going near you are:
- Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery
In addition to providing medical care at no cost, clinical trials enable patients to potentially get access to the latest treatments under development. You can check for currently active clinical studies (research studies) for Epirubicin Hydrochloride. We can advance this treatment together!